Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rockwell Medical, Inc. (RMTI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2800-0.0100 (-0.78%)
At close: 04:00PM EDT
1.2600 -0.02 (-1.56%)
After hours: 07:45PM EDT
Advertisement
Sign in to post a message.
  • R
    Rocky_Raccoon
    Market must be neutral on New CEO. Stock is flat on the day.
  • F
    Frank D
    Anyone else wonder how they managed to appoint a new CEO before the old one even left? Don't most companies do a search to find a replacement????
  • f
    fred
    Ronald --Make " Mailman " happy and tell him you are Franz's twin brother.. --Best--" Bennie "
  • G
    Greg
    new 13d filed by Richmond n crew..over 40% ownership of rmti now...
  • R
    Rocky_Raccoon
    If I were Rockwell, I’d try to get Mark Strobeck to lead this company into its next phase to commercialize HI , AHF and actual sales of Triferic and core business.
  • t
    typea1949
    What will Mark Strobeck do with RMTI?
  • G
    Greg
    Rockwell Medical drops 14% as CEO departs

    Jun. 22, 2022 8:26 AM ETRockwell Medical, Inc. (RMTI)By: Dulan Lokuwithana, SA News Editor



    http://www.fotogestoeber.de/iStock via Getty Images

    Rockwell Medical (NASDAQ:RMTI) shed ~14% in the pre-market Wednesday after the healthcare supplier announced the resignation of its President and Chief Executive Officer, Russell Ellison, effective June 30.

    Mark Strobeck is expected to take over as the company’s new president and chief executive officer, effective July 01.

    Ellison, who led the company since April 2020, will also leave his membership in the company's board of directors.

    Before joining Rockwell (RMTI), Strobeck was a managing partner at Aquilo Partners, a life sciences investment banking firm specialized in M&A and strategic partnerships.

    Strobeck has also served as Chief Operating Officer at Zyla Lifesciences, President and CEO of Corridor Pharmaceuticals, and Chief Business Officer
  • R
    Rocky_Raccoon
    The market seems really happy. Mark Strobeck will be the IRON KING of the world. 1 BILLION in sales. and sells company for 25 billion
  • R
    Rocky_Raccoon
    Market must like the new CEO. Up over 1% today and it’s not even noon!
  • f
    fred
    Wishing all an enjoyable / safe July 4th weekend . --" Bennie "
  • M
    Mallingan
    On June 16, 2022 Rockwell Medical closed the second $7.5 million tranche of the previously announced DaVita, Inc (NYSE:DVA) stock purchase agreement under which DaVita agreed to purchase up to $15 million in convertible preferred stock in two tranches. This investment, in addition to the recently announced $15 million financing, brings the total gross amount raised by Rockwell this quarter to $30 million
    Bullish
  • G
    Greg
    welcone new ceo....all 3 former ceo job led his firms to be acquired....
  • R
    Rocky_Raccoon
    If I were Mark Strobeck, I’d sell this company for $100 per share. Heck, I’d even throw in Calcitriol for that price.
  • S
    Sharon
    Losing 34000 is devastating to us on ss. Went from5000 shares to 450. How can they get away with this rs. RUSSEL LIED TO ME.
  • G
    Greg
    over 38 mil in cash now..60 mil in sales and mkt cap 13 mil...
  • R
    Renalman
    I have owned thousands of shares of RMTI since 1999. I have sold some over the years. I am a believer in RMTI and its products. Rob Chioni had this company moving forward until the board got greedy and felt that things weren't moving fast enough. Rob created Rockwell and its products in his garage. He developed it into a respected dialysis company. What a mistake the board made in squeezing him out. He was a grinder and a worker and made things happen. He walked the talk and communicated with shareholders and held symposiums for possible new shareholders, one of which I attended in Minnesota.Rob was always on his way to Washington to talk to Medicare, CMS, lobbyists and Congressmen about the great news about Trifferc and Citrapure. He was almost there and had the rug pulled out from under him. He took Triferic through the FDA approval process -- which means it is effective and it works.Two important and long-term members of Rockwell have left the medical team -- Dr. Pratt and Dr. Grupta. They were "rock stars" and instrumental in getting Triferic FDA approved. Never heard why?? No longer valuable?? A falling out??How can any executive feel it is ok to treat shareholders poorly and dilute their stock by 90%!! Sure, they say we had the vote to do so, and it was needed. However, the big investors with the most to lose have "crashed" this company. Since they own a large majority of the shares, your vote equals the number of shares you have. (Now that is real equity to us the bottom dwellers)!!�So, what is the end game here?? Something is fishy??A 1/11 reverse split was crippling to many investors. The investor that owns 111,000 shares, woke up the next morning owning 10,000 shares.�We were told if the split was equitable the diluted shares should be valued at $2.31/share. It traded above $2.00 briefly. Yesterday it was down to $1.39/share. Today it closed at $1.64.�Taking the same old bath again!!What bothers me, as a loyal investor is, I get hit big time "below the belt", lose thousands of shares and it is just "another day in the neighborhood". Now some institution can step in because of my huge loss of shares and pick up thousands at a low price. My potential gains are now less than 10 percent. The institution going forward will not lose shares. This is "white collar" bank robbery as far as I'm concerned!!!No one cares!!�Now the stock is tanking. Probably shorted again due to #$%$ off" long term loyal investors like me. Management never appeared to be "grinding" to come up with some real positive news that would have generated some real positive interest. Instead, they just "kicked the can down the road" with an appeasement deal with Davita that should have been done a long time ago.�Never any foresight, just possible deals in the wind.Investors have not, for a very long time, received some uplifting and positive news during a conference call. It is always the same old, I have to be here, drivel. How, about some positive and exciting news and delivery.�Pound your chest and be excited!!In a very short time, I the "average Joe" investor of 19 years gets screwed with a criminal 1/11 reverse split, because this management team cannot perform and sell the best dialysis product available -- Triferic. Studies, Physicians and Patients confirm this. IT IS FDA APPROVED WHICH MEANS IT WORKS!!!!!!!�I am just sick for all of the long-term investors that have supported RMTI. The recent management teams have free shares handed to them and great salaries and benefits. However, they have never stepped up and purchased shares to demonstrate confidence in Rockwell to all investors. Little boys in big man pants that don't fit.Wow!! I am so #$%$ and so sad!! Potential is only a possibility. Hard work makes it happen!!I am out!!!!!!!
    Bearish
  • t
    typea1949
    What kind of an exit package did Russell Ellison receive?
  • F
    Frank D
    Now What???? Down 13.5 % pre-market??
  • B
    Benoite
    Wishing all Dads a happy Father's Day --Be safe --" Bennie "
  • R
    Rocky_Raccoon
    PoorBro, Bio is right. You did say Rockwell is going out of business because they have more debt than cash. Your comparison is poor. Plus Rockwell is only one of a limited number of development stage biopharmas that has any revenue at all. In fact, revenue will be climbing by 30% from 60 million to 75 million plus. You continue to ignore the fact that 99% of ALL development stage biopharmas are down 98% and Rockwell is one of only a few to have actual revenues. Why not compare Rockwell to other biopharmas instead of responding to bios Amazon comparison. You’re a fool to do so and why you can’t compare Rockwells cash raises and price that is exactly similar to its peer group. Go back to Axcan and give a real response!
Advertisement
Advertisement